openPR Logo
Press release

Hyperlipidemia Market 2024 Analysis By Size, Share, Growth, Trends Up To 2033 | Pfizer Inc., Johnson and Johnson Limited, Merck and Co. Inc., AbbVie Inc

08-09-2024 09:13 AM CET | Health & Medicine

Press release from: The Business Research Company

Hyperlipidemia Global Market Report 2024

Hyperlipidemia Global Market Report 2024

"The new report published by The Business Research Company, titled Hyperlipidemia Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the hyperlipidemia market size has grown steadily in recent years. It will grow from $19.41 billion in 2023 to $20.24 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The hyperlipidemia market size is expected to see steady growth in the next few years. It will grow to $23.25 billion in 2028 at a compound annual growth rate (CAGR) of 3.5%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=12873&type=smp

Elevating Demand In The Hyperlipidemia Market Driven By Rising Incidences Of Heart Disease
Increasing incidences of chronic disorders such as heart disease are expected to propel the growth of the hyperlipidemia market going forward. Heart diseases refer to diseases that affect the heart and its functioning. Hyperlipidemia treatment helps people suffering from heart disease by lowering the risk of heart attacks, preventing strokes, improving endothelial function and reducing the need for invasive interventions. For instance, in March 2022, according to a report published by The Office for National Statistics, a UK-based government department, the number of deaths due to heart attacks increased from 19,440 in 2020 to 20,061 in 2021. Therefore, increasing incidences of chronic disorders such as heart disease drive the growth of the hyperlipidemia market.

Innovative Products Drive Competitive Advantage For Leading Companies In The Hyperlipidemia Market
Major companies operating in the hyperlipidemia market are focused on developing innovative products, such as advanced lipid-lowering therapies, to sustain their position in the market. For example, in December 2021, Novartis, a US-based pharmaceutical company, launched a new hyperlipidemia drug called Leqvio (inclisiran), approved by the Food and Drug Administration, a US-based government agency. This is the first-in-class siRNA (small interfering RNA) drug that is used to lower cholesterol as an adjunct treatment to diet and statin therapy for adults with clinical atherosclerotic cardiovascular disease (ASCVD) and heterozygous familial hypercholesterolemia (HeFH) who require additional lowering of low-density lipoprotein cholesterol (LDL-C).

The hyperlipidemia market covered in this report is segmented -

1) By Type: Familial; Acquired
2) By Treatment: Statins; PCSK9 Inhibitors; Bile Acid Sequestrants; Cholesterol Absorption Inhibitors; Fibric Acid Derivatives; Combination; Other Treatment
3) By Route of Administration: Oral; Parenteral
4) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12873&type=discount

Major players in the hyperlipidemia market are Pfizer Inc., Johnson and Johnson Limited, Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, GlaxoSmithKline plc., Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Menarini Group, Ipsen S.A., Dr. Reddy's Laboratories Ltd., Apotex Inc., Hikma Pharmaceuticals PLC, Cipla Inc., Endo International PLC, Aspen Pharmacare Holdings Limited, Zydus Lifesciences Ltd., LEO Pharma A/S.

Contents of the report:
1. Executive Summary
2. Hyperlipidemia Market Report Structure
3. Hyperlipidemia Market Trends And Strategies
4. Hyperlipidemia Market - Macro Economic Scenario
5. Hyperlipidemia Market Size And Growth
…..
27. Hyperlipidemia Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/hyperlipidemia-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hyperlipidemia Market 2024 Analysis By Size, Share, Growth, Trends Up To 2033 | Pfizer Inc., Johnson and Johnson Limited, Merck and Co. Inc., AbbVie Inc here

News-ID: 3616888 • Views:

More Releases from The Business Research Company

Company Registration Service Market Landscape 2025: Forecast Data and Growth Strategy Insights
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Company Registration Service Market Through 2025? The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecasts, and Growth Drivers
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025? In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market in 2025: Advancement In Digital Insurance Platforms Transforms Small And Medium Enterprises Coverage With Integrated, Data-Driven Solutions
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025? The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due To Rising Environmental Monitoring Requirements: Strengthening the Growth Trajectory of the Combustion Emissions Analyzer Market
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025? In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth

All 5 Releases


More Releases for Hyperlipidemia

Top Trends Transforming the Hyperlipidemia Market Landscape in 2025: Revolutiona …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts What Will the Hyperlipidemia Industry Market Size Be by 2025? The market size for hyperlipidemia has seen consistent growth over the previous years. Its projected expansion from $20.24 billion in 2024 to $21.03 billion in 2025, represents a compound annual growth rate (CAGR) of 3.9%. Factors contributing to this
Elevating Demand In The Hyperlipidemia Market Driven By Rising Incidences Of Hea …
The Hyperlipidemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Hyperlipidemia Market? In the past few years, the hyperlipidemia market has experienced consistent growth. It is projected to increase from $20.24 billion in 2024 to $21.03 billion in 2025,
Key Trend Reshaping the Hyperlipidemia Market in 2025: Revolutionary Advances in …
What industry-specific factors are fueling the growth of the hyperlipidemia market? The prevalence of chronic ailments like heart disease is anticipated to drive the advancement of the hyperlipidemia market. Hyperlipidemia treatments are beneficial to individuals with heart conditions, as they lower heart attack risks, help in stroke prevention, enhance endothelial function, and minimize the requirement for invasive procedures. For example, the British Heart Foundation provided data in September 2024 citing that
Prominent Hyperlipidemia Market Trend for 2025: Revolutionary Advances in Hyperl …
What Are the Projected Growth and Market Size Trends for the Hyperlipidemia Market? The hyperlipidemia market is expected to grow from $20.24 billion in 2024 to $21.03 billion in 2025, at a CAGR of 3.9%. This growth is attributed to the increasing demand for effective treatments, growing public awareness, geographic expansion, and factors such as tobacco use. The Hyperlipidemia market will grow to $24.3 billion by 2029 at a CAGR of 3.7%.
Hyperlipidemia Treatment Market Size 2034
Hyperlipidemia Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Hyperlipidemia Therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence. DelveInsight's "Hyperlipidemia Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Hyperlipidemia, historical and forecasted epidemiology as well
Hyperlipidemia Market Trends 2024-2033: Outlook and Insights
"The Business Research Company recently released a comprehensive report on the Global Vanadium Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, the vanadium market size has grown